{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:31:54Z","timestamp":1775259114270,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["106617"],"award-info":[{"award-number":["106617"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["106665"],"award-info":[{"award-number":["106665"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"AIHS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.yjmcc.2018.10.023","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T17:45:34Z","timestamp":1540748734000},"page":"162-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites"],"prefix":"10.1016","volume":"125","author":[{"given":"Nobutoshi","family":"Matsumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid H.","family":"Maayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Parajuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikole J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif M.","family":"Shoieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie-Lynn M.","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna L.","family":"Beker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.B.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.amjmed.2005.08.010","article-title":"Management of post-myocardial infarction patients with left ventricular systolic dysfunction","volume":"120","author":"Gheorghiade","year":"2007","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4037\/ccn2012877","article-title":"Recognizing and managing asymptomatic left ventricular dysfunction after myocardial infarction","volume":"28","author":"Albert","year":"2008","journal-title":"Crit. Care Nurse"},{"issue":"6","key":"10.1016\/j.yjmcc.2018.10.023_bb0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbadis.2014.10.016","article-title":"Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases","volume":"1852","author":"Zordoky","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ajpath.2012.11.009","article-title":"Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway","volume":"182","author":"Kanamori","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.10.023_bb0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10557-008-6141-8","article-title":"Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction","volume":"22","author":"Chen","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.10.023_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128978","article-title":"Resveratrol Upregulates Cardiac SDF-1 in mice with Acute Myocardial Infarction through the Deacetylation of Cardiac p53","volume":"10","author":"Hong","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.yjmcc.2018.10.023_bb0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.787440","article-title":"Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1","volume":"119","author":"Dolinsky","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4238\/2014.January.17.17","article-title":"Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure","volume":"13","author":"Gu","year":"2014","journal-title":"Genetics and molecular research"},{"issue":"10","key":"10.1016\/j.yjmcc.2018.10.023_bb0045","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/carcin\/bgh183","article-title":"Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells","volume":"25","author":"Chen","year":"2004","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2010.08.010","article-title":"Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor alpha expression in human breast cancer cells","volume":"299","author":"Macpherson","year":"2010","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.10.023_bb0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0026-895X(24)12538-2","article-title":"Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol","volume":"56","author":"Ciolino","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00204-014-1419-z","article-title":"5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-kappaB-dependent mechanism","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00204-015-1620-8","article-title":"The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0070","first-page":"207","article-title":"Regulation of cytochrome p450 by inflammatory mediators: why and how?","volume":"29","author":"Morgan","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.88.1.70","article-title":"Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth","volume":"88","author":"Wen","year":"2001","journal-title":"Circ. Res."},{"issue":"46","key":"10.1016\/j.yjmcc.2018.10.023_bb0080","doi-asserted-by":"crossref","first-page":"29055","DOI":"10.1016\/S0021-9258(19)62012-0","article-title":"Modulation of the beta-adrenergic response of cardiomyocytes by specific lipoxygenase products involves their incorporation into phosphatidylinositol and activation of protein kinase C","volume":"269","author":"Wallukat","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.yjmcc.2018.10.023_bb0085","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20082596","article-title":"Cardiac 12\/15 lipoxygenase-induced inflammation is involved in heart failure","volume":"206","author":"Kayama","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/03602530600632063","article-title":"The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases","volume":"38","author":"Korashy","year":"2006","journal-title":"Drug Metab. Rev."},{"issue":"3\u20134","key":"10.1016\/j.yjmcc.2018.10.023_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.prostaglandins.2011.12.003","article-title":"Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents","volume":"98","author":"Malik","year":"2012","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"12","key":"10.1016\/j.yjmcc.2018.10.023_bb0100","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.02-0138com","article-title":"Testosterone, cytochrome P450, and cardiac hypertrophy","volume":"16","author":"Thum","year":"2002","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.yjmcc.2018.10.023_bb0105","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug metabolism and disposition"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.111.183301","article-title":"Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice","volume":"59","author":"Jennings","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0120","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/s41598-018-20613-9","article-title":"2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy","volume":"8","author":"Maayah","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10557-014-6510-4","article-title":"Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats","volume":"28","author":"Jennings","year":"2014","journal-title":"Cardiovascular drugs and therapy \/ sponsored by the International Society of Cardiovascular Pharmacotherapy"},{"key":"10.1016\/j.yjmcc.2018.10.023_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phrs.2015.12.016","article-title":"CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism","volume":"105","author":"Maayah","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.10.023_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.110.154518","article-title":"Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology","volume":"56","author":"Jennings","year":"2010","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.yjmcc.2018.10.023_bb0140","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1042\/CS20171122","article-title":"Cardiovascular susceptibility to in vivo ischemic myocardial injury in male and female rat offspring exposed to prenatal hypoxia","volume":"131","author":"Shah","year":"2017","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0145","doi-asserted-by":"crossref","first-page":"H561","DOI":"10.1152\/ajpheart.00604.2016","article-title":"A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy","volume":"312","author":"Matsumura","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2018.10.023_bb0150","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/cvr\/cvy064","article-title":"Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes","volume":"114","author":"Matsumura","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2018.10.023_bb0155","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1113\/jphysiol.2012.230490","article-title":"Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats","volume":"590","author":"Dolinsky","year":"2012","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0005-2760(84)90012-2","article-title":"Fatty acid oxidation in human and rat heart. Comparison of cell-free and cellular systems","volume":"794","author":"Glatz","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2018.10.023_bb0165","series-title":"Molecular Cloning. A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.yjmcc.2018.10.023_bb0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2013.07.020","article-title":"Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery","volume":"63","author":"Nagendran","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00109-010-0703-5","article-title":"Improved cardiac metabolism and activation of the RISK pathway contributes to improved post-ischemic recovery in calorie restricted mice","volume":"89","author":"Sung","year":"2011","journal-title":"J. Mol. Med."},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2018.10.023_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-017-2943-y","article-title":"The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol","volume":"429","author":"Maayah","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","article-title":"Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats","volume":"242","author":"Zordoky","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.yjmcc.2018.10.023_bb0190","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.115.063776","article-title":"Early changes in Cytochrome P450s and their Associated Arachidonic Acid Metabolites Play a crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol","volume":"43","author":"Althurwi","year":"2015","journal-title":"Drug metabolism and disposition"},{"issue":"9","key":"10.1016\/j.yjmcc.2018.10.023_bb0195","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1124\/dmd.114.057836","article-title":"Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As","volume":"42","author":"El-Sherbeni","year":"2014","journal-title":"Drug metabolism and disposition"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.taap.2013.07.005","article-title":"Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling","volume":"272","author":"Lo","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.10.023_bb0205","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cardiores.2006.08.020","article-title":"Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart","volume":"72","author":"Heather","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0008-6363(01)00393-5","article-title":"Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism","volume":"52","author":"Rosenblatt-Velin","year":"2001","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.10.023_bb0220","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.yjmcc.2018.10.023_bb0225","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.bbadis.2013.05.018","article-title":"Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice","volume":"1832","author":"Dolinsky","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.yjmcc.2018.10.023_bb0230","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/dmd.32.8.840","article-title":"Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1","volume":"32","author":"Choudhary","year":"2004","journal-title":"Drug metabolism and disposition"},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2018.10.023_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-017-2943-y","article-title":"The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol","volume":"429","author":"Maayah","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"7117","key":"10.1016\/j.yjmcc.2018.10.023_bb0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure","volume":"86","author":"Konstam","year":"1992","journal-title":"SOLVD Investigators, Circulation"},{"issue":"11","key":"10.1016\/j.yjmcc.2018.10.023_bb0255","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/CIRCULATIONAHA.105.538272","article-title":"Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy","volume":"112","author":"Yu","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-012-9324-0","article-title":"Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training","volume":"18","author":"Conraads","year":"2013","journal-title":"Heart Fail. Rev."},{"issue":"10","key":"10.1016\/j.yjmcc.2018.10.023_bb0265","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1096\/fj.10-177295","article-title":"Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat","volume":"25","author":"Momken","year":"2011","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.10.023_bb0270","doi-asserted-by":"crossref","first-page":"H842","DOI":"10.1152\/ajpheart.00455.2016","article-title":"Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure","volume":"312","author":"Sung","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(98)00073-X","article-title":"Cardiovascular phenotyping in mice","volume":"39","author":"Doevendans","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2018.10.023_bb0280","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/00365516109137305","article-title":"Myocardial metabolism of glucose, lactic acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads","volume":"13","author":"Carlsten","year":"1961","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.10.023_bb0285","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jtcvs.2010.08.003","article-title":"Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression","volume":"140","author":"Amorim","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.10.023_bb0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.yjmcc.2018.10.023_bb0295","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1073\/pnas.78.9.5362","article-title":"Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid","volume":"78","author":"Capdevila","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.10.023_bb0300","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0952-3278(91)90087-L","article-title":"Gas chromatographic-mass spectrometric analysis of lipoxygenase products in post-ischemic rabbit myocardium","volume":"42","author":"Hughes","year":"1991","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"8","key":"10.1016\/j.yjmcc.2018.10.023_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161629","article-title":"The Arachidonate 15-Lipoxygenase Enzyme Product 15-HETE is present in Heart Tissue from patients with Ischemic Heart Disease and Enhances Clot Formation","volume":"11","author":"Lundqvist","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.10.023_bb0310","doi-asserted-by":"crossref","first-page":"H269","DOI":"10.1152\/ajpheart.00604.2014","article-title":"Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction","volume":"308","author":"Lopez","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2018.10.023_bb0315","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/01.RES.0000146277.62128.6f","article-title":"Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway","volume":"95","author":"Nithipatikom","year":"2004","journal-title":"Circ. Res."},{"issue":"1\u20133","key":"10.1016\/j.yjmcc.2018.10.023_bb0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.08.008","article-title":"Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1\/2 signaling in rat myocardial ischemia-reperfusion","volume":"596","author":"Lv","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.10.023_bb0325","doi-asserted-by":"crossref","first-page":"H2128","DOI":"10.1152\/ajpheart.00428.2008","article-title":"Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo","volume":"295","author":"Motoki","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.10.023_bb0330","doi-asserted-by":"crossref","first-page":"H724","DOI":"10.1152\/ajpheart.00979.2007","article-title":"Multiple antiapoptotic targets of the PI3K\/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia\/anoxia","volume":"294","author":"Dhanasekaran","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.10.023_bb0335","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-3565(24)29205-3","article-title":"Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2","volume":"299","author":"Chang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281830720X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281830720X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:10:20Z","timestamp":1775254220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228281830720X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":67,"alternative-id":["S002228281830720X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.023","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}